Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 192

The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.

The International Society for Bipolar Disorders (ISBD) consensus guidelines for the safety monitoring of bipolar disorder treatments

Open access
Ng, Felicity, Mammen, Oommen K, Wilting, Ingeborg, Sachs, Gary S, Ferrier, I Nicol, Cassidy, Frederick, Beaulieu, Serge, Yatham, Lakshmi N, Berk, Michael·2009·Bipolar Disorders
DOI 10.1111/j.1399-5618.2009.00737.x
Open this paper in CoChat — free account

Abstract

Objectives: Safety monitoring is an important aspect of bipolar disorder treatment, as mood‐stabilising medications have potentially serious side effects, some of which may also aggravate existing medical comorbidities. This paper sets out the International Society for Bipolar Disorders (ISBD) guidelines for the safety monitoring of widely used agents in the treatment of bipolar disorder. These guidelines aim to provide recommendations that take into consideration the balance between safety and cost‐effectiveness, to highlight iatrogenic and preventive clinical issues, and to facilitate the broad implementation of therapeutic safety monitoring as a standard component of treatment for bipolar disorder. Methods: These guidelines were developed by an ISBD workgroup, headed by the senior author (MB), through an iterative process of serial consensus‐based revisions. After this, feedback from a multidisciplinary group of health professionals on the applicability of these guidelines was sought to develop the final recommendations. Results: General safety monitoring recommendations for all bipolar disorder patients receiving treatment and specific monitoring recommendations for individual agents are outlined. Conclusions: These guidelines are derived from evolving and often indirect data, with minimal empirical cost‐effectiveness data available to provide guidance. These guidelines will therefore need to be modified to adapt to different clinical settings and health resources. Clinical acumen and vigilance remain critical ingredients for safe treatment practice.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1399-5618.2009.00737.x

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 32 references

Research works printed but not linked: 262

  1. 10.1001/jama.293.20.2528 · DOI · Paper page
  2. 10.1176/ps.2006.57.8.1140 · DOI
  3. 10.1016/j.jad.2007.01.006 · DOI
  4. 10.1001/jama.282.15.1458 · DOI · Paper page
  5. 10.1176/appi.ajp.161.8.1334 · DOI · Paper page
  6. 10.2337/diacare.27.2.596 · DOI · Paper page
  7. Expert Group, 2004, ‘Schizophrenia and Diabetes 2003’ Expert Consensus Meeting, Dublin, 3–4 October 2003: consensus summary, Br J Psychiatry Suppl, 47, S112
  8. 10.2165/00023210-200721020-00003 · DOI
  9. American Psychiatric Association, 2002, Practice guideline for the treatment of patients with bipolar disorder (revision), Am J Psychiatry, 159, 1
  10. 10.1097/00004583-200503000-00006 · DOI · Paper page
  11. Masand PS, 2005, Metabolic and endocrine disturbances in psychiatric disorders: a multidisciplinary approach to appropriate atypical antipsychotic utilization, CNS Spectr, 10, 1, 10.1017/S1092852900025499 · DOI
  12. 10.1111/j.1399-5618.2005.00234.x · DOI · Paper page
  13. 10.1111/j.1399-5618.2004.00138.x · DOI · Paper page
  14. 10.1161/01.CIR.0000111245.75752.C6 · DOI · Paper page
  15. 10.1007/s11920-007-0071-1 · DOI
  16. 10.2337/dc07-0585 · DOI · Paper page
  17. Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults, 2001, JAMA, 2486
  18. 10.1080/10673220216208 · DOI
  19. 10.1111/j.1600-0447.2005.00521.x · DOI
  20. 10.1176/appi.ajp.162.10.1805 · DOI · Paper page
  21. 10.1001/jama.290.11.1467 · DOI · Paper page
  22. 10.1016/S0010-9452(08)70041-8 · DOI
  23. Hansen HE, 1978, Lithium intoxication. (Report of 23 cases and review of 100 cases from the literature), Q J Med, 47, 123
  24. 10.1046/j.1365-2125.1999.00033.x · DOI
  25. 10.1681/ASN.V103666 · DOI · Paper page
  26. 10.1046/j.1440-1614.2001.00963.x · DOI
  27. 10.1176/ajp.137.8.941 · DOI
  28. Delva NJ, 2001, Preventing lithium intoxication. Guide for physicians, Can Fam Physician, 47, 1595
  29. 10.1192/bjp.162.5.689 · doi:10.1192/bjp.162.5.689
  30. 10.1097/00007611-198411000-00030 · DOI
  31. 10.1016/S0272-6386(87)80098-7 · DOI · Paper page
  32. 10.1681/ASN.V1181439 · DOI · Paper page
  33. 10.1046/j.1523-1755.2003.00096.x · DOI · Paper page
  34. Bendz H, 1994, Kidney damage in long‐term lithium patients: a cross‐sectional study of patients with 15 years or more on lithium, Nephrol Dial Transplant, 9, 1250
  35. 10.4088/JCP.v65n0618 · DOI
  36. 10.7326/0003-4819-144-3-200602070-00007 · DOI · Paper page
  37. 10.1016/j.semnephrol.2008.03.002 · DOI
  38. 10.1111/j.0954-6820.1980.tb09726.x · DOI
  39. 10.1192/bjp.182.4.319 · DOI
  40. 10.1111/j.1600-0447.1985.tb02639.x · DOI
  41. 10.1111/j.1600-0447.1981.tb00682.x · DOI
  42. 10.1093/oxfordjournals.ndt.a027311 · DOI
  43. 10.1177/003693309704200106 · DOI
  44. 10.2165/00002018-199921060-00002 · DOI
  45. 10.1192/bjp.159.1.83 · doi:10.1192/bjp.159.1.83
  46. 10.1111/j.1365-2265.1995.tb01894.x · DOI · Paper page
  47. 10.1097/00004714-200112000-00009 · DOI
  48. 10.1192/bjp.175.4.336 · DOI
  49. 10.1016/S0006-3223(01)01217-3 · DOI · Paper page
  50. 10.1016/0026-0495(90)90014-4 · DOI
  51. 10.1111/j.1600-0447.1987.tb02778.x · doi:10.1111/j.1600-0447.1987.tb02778.x
  52. 10.1016/0002-9343(82)90922-6 · DOI · Paper page
  53. 10.1007/s00268-002-6824-4 · DOI
  54. 10.1210/jc.82.9.2844 · DOI
  55. Lienert D, 2008, Moans, stones, groans, bones and psychiatric overtones: lithium‐induced hyperparathyroidism, Aust N Z J Psychiatry, 42, 171
  56. 10.1016/j.cccn.2004.10.003 · doi:10.1016/j.cccn.2004.10.003
  57. 10.1111/j.1399-5618.2006.00308.x · DOI
  58. 10.1176/ajp.2006.163.7.1199 · doi:10.1176/ajp.2006.163.7.1199
  59. 10.1111/j.1600-0447.1976.tb00067.x · DOI
  60. 10.1111/j.1600-0447.1988.tb06363.x · DOI
  61. 10.4088/JCP.v64n1108 · DOI
  62. 10.2165/00003088-199529030-00004 · DOI · Paper page
  63. 10.1097/00004850-200503000-00010 · DOI
  64. 10.1186/1745-0179-2-23 · DOI
  65. 10.1093/med/9780198527480.003.0012 · doi:10.1093/med/9780198527480.003.0012
  66. 10.1111/j.1528-1157.2000.tb02945.x · DOI
  67. 10.1177/106002809002401214 · DOI
  68. 10.1097/MOH.0b013e3282f15fb9 · DOI · Paper page
  69. 10.1016/S0140-6736(05)66515-4 · DOI · Paper page
  70. 10.1111/j.1528-1167.2006.00596.x · DOI
  71. Kaufman DW, 1996, Drugs in the aetiology of agranulocytosis and aplastic anaemia, Eur J Haematol Suppl, 60, 23, 10.1111/j.1600-0609.1996.tb01641.x · DOI · Paper page
  72. 10.1345/aph.17445 · DOI
  73. 10.1111/j.1365-4632.2008.03637.x · DOI
  74. 10.1002/j.1875-9114.1998.tb03148.x · DOI · Paper page
  75. 10.1097/00043426-200001000-00012 · DOI · Paper page
  76. 10.1592/phco.21.17.1325.34418 · DOI
  77. 10.1111/j.1528-1167.2006.00587.x · DOI
  78. 10.1111/j.1600-0404.1994.tb01673.x · doi:10.1111/j.1600-0404.1994.tb01673.x
  79. 10.1111/j.1528-1157.1987.tb05780.x · DOI · Paper page
  80. 10.2165/00002018-200730040-00001 · DOI · Paper page
  81. 10.1056/NEJMra052270 · DOI · Paper page
  82. 10.1111/j.1528-1157.1987.tb05768.x · DOI
  83. Pirmohamed M, 2007, Drug‐Induced Liver Disease, 485
  84. 10.1111/j.1365-2125.2004.02133.x · DOI · Paper page
  85. 10.1136/gut.25.6.673 · DOI · Paper page
  86. Wyllie E, 1991, Routine laboratory monitoring for serious adverse effects of antiepileptic medications: the controversy, Epilepsia, 32, S74
  87. 10.1212/WNL.46.2.465 · DOI · Paper page
  88. 10.1212/WNL.37.3.379 · DOI · Paper page
  89. 10.1016/j.clindermatol.2005.02.001 · doi:10.1016/j.clindermatol.2005.02.001
  90. 10.1016/j.tripleo.2006.12.008 · DOI
  91. 10.1001/archderm.1993.01680220104023 · doi:10.1001/archderm.1993.01680220104023 · Paper page
  92. 10.1016/j.jaad.2006.04.048 · DOI · Paper page
  93. 10.1001/archderm.138.8.1019 · doi:10.1001/archderm.138.8.1019
  94. 10.1016/j.jaad.2007.08.039 · doi:10.1016/j.jaad.2007.08.039
  95. 10.1212/01.WNL.0000156354.20227.F0 · DOI · Paper page
  96. 10.1056/NEJM199512143332404 · DOI · Paper page
  97. 10.2165/00002018-200427030-00002 · DOI
  98. 10.4088/JCP.v63n1110 · DOI · Paper page
  99. 10.1111/j.1528-1157.1999.tb00807.x · DOI · Paper page
  100. 10.1007/s00198-006-0185-z · DOI · Paper page
  101. 10.4065/81.5.662 · DOI
  102. 10.1212/01.wnl.0000299751.87703.c5 · doi:10.1212/01.wnl.0000299751.87703.c5
  103. 10.1212/01.wnl.0000188819.45330.90 · DOI · Paper page
  104. 10.1111/j.1528-1157.1994.tb02930.x · DOI · Paper page
  105. 10.1055/s-2002-33046 · DOI
  106. 10.1159/000086019 · DOI · Paper page
  107. 10.1016/j.amjmed.2006.05.013 · DOI
  108. 10.1016/0278-5846(94)90055-8 · doi:10.1016/0278-5846(94)90055-8
  109. 10.1080/10673220801924308 · DOI
  110. 10.2165/00023210-200317110-00002 · DOI
  111. 10.1016/j.seizure.2005.09.011 · DOI
  112. 10.1034/j.1600-0404.2003.00093.x · DOI · Paper page
  113. 10.1212/WNL.56.2.172 · DOI · Paper page
  114. 10.4088/JCP.v63n1210 · DOI · Paper page
  115. 10.1176/appi.ajp.160.7.1263 · DOI · Paper page
  116. 10.1016/j.amjmed.2006.06.029 · DOI
  117. 10.1002/ana.410430406 · DOI · Paper page
  118. 10.1212/01.WNL.0000048209.07526.86 · DOI
  119. 10.1111/j.1468-1331.2004.00899.x · DOI
  120. 10.1046/j.1528-1157.2001.0420081002.x · DOI
  121. 10.1007/s00535-006-1961-4 · doi:10.1007/s00535-006-1961-4
  122. 10.1542/peds.2006-1182 · doi:10.1542/peds.2006-1182
  123. 10.1046/j.1528-1157.2002.18502.x · doi:10.1046/j.1528-1157.2002.18502.x
  124. 10.1111/j.1600-0404.2006.00655.x · DOI · Paper page
  125. 10.1016/j.yebeh.2007.02.013 · DOI
  126. 10.1111/j.1528-1167.2006.00671.x · DOI
  127. 10.1016/j.ogc.2007.02.001 · DOI
  128. 10.1097/YCO.0b013e328010e29b · DOI
  129. 10.1001/archpsyc.64.4.442 · DOI · Paper page
  130. 10.1097/00132580-200205000-00009 · DOI
  131. 10.1016/j.schres.2006.08.017 · DOI · Paper page
  132. 10.1080/10401230500464596 · DOI
  133. Newcomer JW, 2007, Metabolic considerations in the use of antipsychotic medications: a review of recent evidence, J Clin Psychiatry, 68, 20
  134. Newcomer JW, 2007, Antipsychotic medications: metabolic and cardiovascular risk, J Clin Psychiatry, 68, 8
  135. 10.1017/S1461145705005183 · DOI
  136. 10.1176/ajp.2006.163.10.1821 · DOI
  137. 10.4088/JCP.v68n1107 · DOI
  138. 10.4088/JCP.v67n0707 · DOI
  139. 10.1592/phco.27.1.27 · DOI
  140. 10.4088/JCP.v68n0407 · DOI
  141. 10.1177/0885066606295823 · DOI
  142. 10.1111/j.1464-5491.2005.01628.x · DOI
  143. Reddymasu S, 2006, Elevated lipase and diabetic ketoacidosis associated with aripiprazole, JOP, 7, 303
  144. 10.2190/B9RD-VMC4-CU8C-KFDD · DOI · Paper page
  145. 10.1002/hup.915 · DOI · Paper page
  146. 10.1136/bmj.322.7296.1207 · DOI · Paper page
  147. 10.1517/14740338.4.4.731 · DOI
  148. 10.2165/00002018-200730010-00005 · DOI · Paper page
  149. 10.1016/S0140-6736(99)10385-4 · DOI · Paper page
  150. 10.1176/appi.ajp.158.11.1774 · DOI · Paper page
  151. 10.1016/j.ahj.2007.01.040 · DOI · Paper page
  152. 10.2165/00002018-200427030-00001 · DOI
  153. 10.1097/00004714-200302000-00010 · DOI · Paper page
  154. 10.1001/jama.289.16.2120 · DOI · Paper page
  155. 10.1056/NEJMp048192 · DOI
  156. 10.1001/jama.289.16.2041 · DOI · Paper page
  157. U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research and Center for Biologics Evaluation and Research, 2005, Guidance for Industry: E14 Clinical Evaluation of QT/QTc Interval Prolongation and Proarrhythmic Potential for Non‐Antiarrhythmic Drugs
  158. 10.1097/01.jcp.0000104913.75206.62 · DOI · Paper page
  159. 10.2165/00003495-200464150-00010 · DOI · Paper page
  160. 10.4088/JCP.v69n0115 · DOI
  161. 10.1016/j.schres.2007.12.377 · DOI
  162. 10.1097/01.md.0000085057.63483.9b · DOI · Paper page
  163. 10.1016/j.ecl.2007.10.013 · DOI · Paper page
  164. 10.1592/phco.26.6.748 · DOI
  165. Stubner S, 2004, Blood dyscrasias induced by psychotropic drugs, Pharmacopsychiatry, 37, S70
  166. 10.2165/00002018-200528030-00002 · DOI · Paper page
  167. 10.1080/10673220600748486 · DOI
  168. 10.1097/00131746-200701000-00003 · DOI
  169. 10.1136/bmj.319.7210.623 · DOI · Paper page
  170. 10.1111/j.1440-1665.2006.02267.x · DOI
  171. 10.1097/01.yic.0000201496.23259.85 · DOI
  172. 10.1080/13651500510018310 · DOI
  173. 10.5694/j.1326-5377.2004.tb06443.x · DOI
  174. 10.1017/S1092852900028856 · DOI
  175. 10.1056/NEJMra035092 · DOI · Paper page
  176. Martin A, 2007, Lewis’ Child and Adolescent Psychiatry: A Comprehensive Textbook, 742
  177. 10.2165/00128072-200305040-00005 · doi:10.2165/00128072-200305040-00005
  178. 10.1097/00004714-198810000-00009 · DOI
  179. Scahill L, 2007, Lewis’ Child and Adolescent Psychiatry: A Comprehensive Textbook, 754
  180. Birmaher B, 2007, Lewis’ Child and Adolescent Psychiatry: A Comprehensive Textbook, 513
  181. 10.1097/01.CHI.0000046841.56865.37 · DOI
  182. 10.1097/chi.0b013e3181570d9e · DOI · Paper page
  183. 10.2165/00023210-200721120-00005 · DOI
  184. Correll CU, 2008, Assessing and maximizing the safety and tolerability of antipsychotics used in the treatment of children and adolescents, J Clin Psychiatry, 69, 26
  185. 10.1097/01.chi.0000220851.94392.30 · DOI · Paper page
  186. Silva RR, 1992, Side effects associated with lithium and placebo administration in aggressive children, Psychopharmacol Bull, 28, 319
  187. 10.2165/00128072-200002040-00006 · DOI · Paper page
  188. 10.1097/01.chi.0000242240.69678.c4 · DOI · Paper page
  189. 10.1097/01.CHI.0000046860.56865.25 · doi:10.1097/01.chi.0000046860.56865.25
  190. 10.1136/bmj.2.5859.135 · DOI · Paper page
  191. 10.1001/jama.1994.03510260078033 · DOI · Paper page
  192. 10.1016/0140-6736(92)90346-5 · DOI · Paper page
  193. 10.1111/j.1600-0447.1976.tb00112.x · DOI · Paper page
  194. 10.1002/ajmg.a.30501 · DOI
  195. 10.1176/appi.ajp.162.11.2162 · DOI · Paper page
  196. Viguera AC, 2007, Lithium in breast milk and nursing infants: clinical implications, Am J Psychiatry, 164, 342, 10.1176/ajp.2007.164.2.342 · DOI · Paper page
  197. 10.1097/00007691-200306000-00017 · DOI
  198. 10.1016/S1474-4422(05)70224-6 · DOI · Paper page
  199. 10.1212/01.WNL.0000154516.43630.C5 · DOI · Paper page
  200. 10.2165/00002018-200629010-00001 · DOI

200 of 262 shown

Cited by

See all 192

Metadata

Authors
Ng, F., Mammen, O. K., Wilting, I., Sachs, G. S., Ferrier, I. N., Cassidy, F., Beaulieu, S., Yatham, L. N., & Berk, M.
Venue
Bipolar Disorders
Publisher
Wiley
Published
2009-08-10
Volume
11
Issue
6
Pages
559-595
ISSN
  • 1398-5647 (ISSN-L)
  • 1399-5618
DOI
10.1111/j.1399-5618.2009.00737.x
OpenAlex
W1973735336
Cited by
192
References
32
FWCI
9.23
Type
journal article
Language
en
Open access
bronze
Licence
onlinelibrary.wiley.com/termsAndConditions#vor (vor)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The International Society for Bipolar Disorders (ISBD) consensus guidelines for the safety monitoring of bipolar disorder treatments. https://app.cochat.ai/papers/10.1111/j.1399-5618.2009.00737.x
The paper
Ng, F., Mammen, O. K., Wilting, I., Sachs, G. S., Ferrier, I. N., Cassidy, F., Beaulieu, S., Yatham, L. N., & Berk, M. (2009). The International Society for Bipolar Disorders (ISBD) consensus guidelines for the safety monitoring of bipolar disorder treatments. Bipolar Disorders. https://doi.org/10.1111/j.1399-5618.2009.00737.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.